HRMY
ハーモニー・バイオサイエンシーズ
HRMY
ハーモニー・バイオサイエンシーズ
Harmony Biosciences NASDAQ: HRMY highlighted record quarterly performance for its narcolepsy treatment WAKIX and outlined development plans across its orexin, epilepsy and pitolisant lifecycle-managem
Harmony Biosciences Holdings, Inc. (HRMY) Q2 2026 Earnings Call Transcript